955 Edited1.pdf 894 | Miscellaneous Evaluation of Patency of Arteriovenous Fistula and Its Relative Complications in Diabetic Patients Seyed Saeed Mortaz,1 Ali Davati,1 Maryam Khan Ahmadloo,1 Hamid Reza Taheri,1 Farzaneh Golfam,1 Azin Tavakoli,2 Ali Reza Khalaj1 Purpose: Materials and Methods: - - t Results: - P P Conclusion: Keywords: Corresponding Author: Ali Reza Khalaj, MD Department of Surgery, Faculty of Medical Sciences, Shahed University, Tehran, Iran Tel: +98 21 8897 7927 Fax: +98 21 8896 3122 E-mail: arkhalaj@yahoo.com Received April 2011 Accepted August 2011 1Department of Surgery, Faculty of Medical Sciences, Shahed University, Tehran, Iran 2Faculty of Veterinary Medicine, Islamic Azad University-Garmsar Branch, Garmsar, Iran MISCELLANEOUS 895Vol. 10 | No. 2 | Spring 2013 |U R O LO G Y J O U R N A L INTRODUCTION - - - - - - - - - - - MATERIALS AND METHODS - - - - t P RESULTS - - Table 1. Location of the fistula and duration of patency. Duration of patency (mean ± standard deviation), month Number (%)Location of the fistula 25.27 ± 15.7744.6 (58%) Brachiocephalic Left 24.0 ± 13.7616.2 (21%) Right 170.8 (1%) Radiocephalic Left 15.2 ± 6.683.8 (5%) Right 24.18 ± 18.1229.1 (38%) Anatomical snuffbox area Left 25.27 ± 15.775.4 (7%) Right AV Fistula in Diabetics | Mortaz et al 896 | - P P DISCUSSION - - - st th - - - - - - - - - - - CONCLUSION - CONFLICT OF INTEREST Table 2. Duration of patency in different genders and number of complications in patients. Variable Number Duration of patency (mean ± standard deviation) Gender Male Female 65 65 23.64 ± 15.33 24.83 ± 16.34 Complication Yes No 7 123 19.85 ± 13.6 24.48 ± 15.92 Table 3. Rate of complications in different genders and location of the fistula. Variable Rate of complication, % Gender Male Female 6.2 4.7 Location of fistula Brachiocephalic Radiocephalic 7.7 16.7 Miscellaneous 897Vol. 10 | No. 2 | Spring 2013 |U R O LO G Y J O U R N A L AV Fistula in Diabetics | Mortaz et al REFERENCES 1. Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010;8:29. 2. Baska TV, Nemcova J, Martinka E, Straka S, Mad'ar R. [Epide- miological characteristics of diabetes mellitus in Slovakia, 1992-2002]. Epidemiol Mikrobiol Imunol. 2006;55:68-72. 3. Patel A, MacMahon S, Chalmers J, et al. Intensive blood glu- cose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560-72. 4. Wyatt SB, Winters KP, Dubbert PM. Overweight and obesity: prevalence, consequences, and causes of a growing public health problem. Am J Med Sci. 2006;331:166-74. 5. Quinton W, Dillard D, Scribner BH. Cannulation of blood vessels for prolonged hemodialysis. Hemodial Int. 2004;8:6- 9. 6. Brescia MJ, Cimino JE, Appell K, Hurwich BJ, Scribner BH. Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. 1966. J Am Soc Nephrol. 1999;10:193-9. 7. Baker LD, Jr., Johnson JM, Goldfarb D. Expanded polytetra- fluoroethylene (PTFE) subcutaneous arteriovenous con- duit: an improved vascular access for chronic hemodialysis. Trans Am Soc Artif Intern Organs. 1976;22:382-7. 8. Falk A. Maintenance and salvage of arteriovenous fistulas. J Vasc Interv Radiol. 2006;17:807-13. 9. Srivastava A, Sharma S. Hemodialysis vascular access options after failed Brescia-Cimino arteriovenous fistula. Indian J Urol. 2011;27:163-8. 10. Windus DW. The effect of comorbid conditions on hemodi- alysis access patency. Adv Ren Replace Ther. 1994;1:148-54. 11. Lin SL, Huang CH, Chen HS, Hsu WA, Yen CJ, Yen TS. Effects of age and diabetes on blood flow rate and primary out- come of newly created hemodialysis arteriovenous fistulas. Am J Nephrol. 1998;18:96-100. 12. Sesso R, Melaragno CS, Luconi PS, et al. [Survival of dialyzed diabetic patients]. Rev Assoc Med Bras. 1995;41:178-82. 13. Tuka V, Slavikova M, Svobodova J, Malik J. Diabetes and distal access location are associated with higher wall shear rate in feeding artery of PTFE grafts. Nephrol Dial Trans- plant. 2006;21:2821-4. 14. Resic H, Sahovic V, Mesic E. [Predictors of AV fistula adequa- cy in haemodialysed patients]. Med Arh. 2005;59:177-8. 15. Murphy GJ, Nicholson ML. Autogeneous elbow fistulas: the effect of diabetes mellitus on maturation, patency, and complication rates. Eur J Vasc Endovasc Surg. 2002;23:452- 7. 16. Ernandez T, Saudan P, Berney T, Merminod T, Bednarkiewicz M, Martin PY. Risk factors for early failure of native arterio- venous fistulas. Nephron Clin Pract. 2005;101:c39-44.